BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 28448372)

  • 1. Validity of the Montreal Cognitive Assessment Screener in Adolescents and Young Adults With and Without Congenital Heart Disease.
    Pike NA; Poulsen MK; Woo MA
    Nurs Res; 2017; 66(3):222-230. PubMed ID: 28448372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation.
    Godefroy O; Fickl A; Roussel M; Auribault C; Bugnicourt JM; Lamy C; Canaple S; Petitnicolas G
    Stroke; 2011 Jun; 42(6):1712-6. PubMed ID: 21474808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
    Ozdilek B; Kenangil G
    Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of the Cantonese Chinese Montreal Cognitive Assessment in Southern Chinese.
    Chu LW; Ng KH; Law AC; Lee AM; Kwan F
    Geriatr Gerontol Int; 2015 Jan; 15(1):96-103. PubMed ID: 24456109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validation of the Montreal Cognitive Assessment (MoCA) as a screening tool for mild cognitive impairment in the population of Buenos Aires, Argentina].
    González Palau F; Berrios W; García Basalo MM; Ojea Quintana M; Fernández M; García Basalo MJ; Fernández MC; Cámpora N; Matusevich LD; Golimstok Á
    Vertex; 2018 Jul; XXIX(140):261-269. PubMed ID: 30778419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A validation study of the Hong Kong version of Montreal Cognitive Assessment (HK-MoCA) in Chinese older adults in Hong Kong.
    Yeung PY; Wong LL; Chan CC; Leung JL; Yung CY
    Hong Kong Med J; 2014 Dec; 20(6):504-10. PubMed ID: 25125421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Quick Mild Cognitive Impairment (Qmci) screen to the Montreal Cognitive Assessment (MoCA) in an Australian geriatrics clinic.
    Clarnette R; O'Caoimh R; Antony DN; Svendrovski A; Molloy DW
    Int J Geriatr Psychiatry; 2017 Jun; 32(6):643-649. PubMed ID: 27427212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) for cognitive screening in old age psychiatry: Determining cutoff scores in clinical practice. Avoiding spectrum bias caused by healthy controls.
    Dautzenberg G; Lijmer J; Beekman A
    Int J Geriatr Psychiatry; 2020 Mar; 35(3):261-269. PubMed ID: 31650623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief screening for mild cognitive impairment in subcortical ischemic vascular disease: a comparison study of the Montreal Cognitive Assessment with the Mini-Mental State Examination.
    Xu Q; Cao WW; Mi JH; Yu L; Lin Y; Li YS
    Eur Neurol; 2014; 71(3-4):106-14. PubMed ID: 24335198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of the Montreal Cognitive Assessment in the detection of cognitive dysfunction in Huntington's disease.
    Bezdicek O; Majerova V; Novak M; Nikolai T; Ruzicka E; Roth J
    Appl Neuropsychol Adult; 2013; 20(1):33-40. PubMed ID: 23373682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
    Papastefanakis E; Dimitraki G; Ktistaki G; Fanouriakis A; Karamaouna P; Bardos A; Kallitsakis I; Adamichou C; Gergianaki I; Repa A; Bertsias G; Sidiropoulos P; Karademas E; Simos P
    Lupus; 2021 Dec; 30(14):2237-2247. PubMed ID: 34861804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of--or as well as--the MMSE?
    Larner AJ
    Int Psychogeriatr; 2012 Mar; 24(3):391-6. PubMed ID: 22014176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-cultural difference and validation of the Chinese version of Montreal Cognitive Assessment in older adults residing in Eastern China: preliminary findings.
    Hu JB; Zhou WH; Hu SH; Huang ML; Wei N; Qi HL; Huang JW; Xu Y
    Arch Gerontol Geriatr; 2013; 56(1):38-43. PubMed ID: 22698678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
    Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usability and Validity of a Battery of Computerised Cognitive Screening Tests for Detecting Cognitive Impairment.
    Scanlon L; O'Shea E; O'Caoimh R; Timmons S
    Gerontology; 2016; 62(2):247-52. PubMed ID: 26113397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The validity of the Montreal cognitive assessment (MoCA) for the screening of vascular cognitive impairment after ischemic stroke.
    Potocnik J; Ovcar Stante K; Rakusa M
    Acta Neurol Belg; 2020 Jun; 120(3):681-685. PubMed ID: 32193731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia.
    Gil L; Ruiz de Sánchez C; Gil F; Romero SJ; Pretelt Burgos F
    Int J Geriatr Psychiatry; 2015 Jun; 30(6):655-62. PubMed ID: 25320026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Montreal Cognitive Assessment (MoCA) is superior to the Mini Mental State Examination (MMSE) in detection of Korsakoff's syndrome.
    Oudman E; Postma A; Van der Stigchel S; Appelhof B; Wijnia JW; Nijboer TC
    Clin Neuropsychol; 2014; 28(7):1123-32. PubMed ID: 25249353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of the Montreal Cognitive Assessment in screening for cognitive impairment in patients with newly diagnosed high-grade glioma.
    Ribeiro M; Durand T; Roussel M; Feuvret L; Jacob J; Psimaras D; Noel G; Keller A; Bompaire F; Hoang-Xuan K; Bernier MO; Godefroy O; Ricard D
    J Neurooncol; 2020 Jun; 148(2):335-342. PubMed ID: 32415644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving screening for vascular cognitive impairment at three to six months after mild ischemic stroke and transient ischemic attack.
    Dong Y; Slavin MJ; Chan BP; Venketasubramanian N; Sharma VK; Collinson SL; Sachdev PS; Chen CL
    Int Psychogeriatr; 2014 May; 26(5):787-93. PubMed ID: 24423626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.